CareRx Corporation (TSX:CRRX)
3.180
-0.010 (-0.31%)
Aug 21, 2026, 3:49 PM EST
CareRx Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, CareRx stock has a consensus rating of "Strong Buy" and an average price target of $5.14. The average 1-year stock price forecast is 61.64% higher than the current stock price, while the lowest is $4.25 (+33.65%) and the highest is $6.25 (+96.54%).
Price Target: $5.14 (+61.64%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CareRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 3 | 2 | 2 | 2 | 2 | 3 |
| Hold | 0 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $4.50 | Buy | Maintains | $4.50 | +41.51% | Jul 31, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $5.00 | Buy | Maintains | $5.00 | +57.23% | Jul 31, 2026 |
| ATB Cormark Capital Markets | ATB Cormark Capital Markets | Buy Maintains $6.25 | Buy | Maintains | $6.25 | +96.54% | May 11, 2026 |
Financial Forecast
Revenue This Year
382.14M
from 370.24M
Increased by 3.21%
Revenue Next Year
403.81M
from 382.14M
Increased by 5.67%
EPS This Year
0.20
from 0.04
Increased by 374.45%
EPS Next Year
0.30
from 0.20
Increased by 53.85%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.